Key TakeawaysCerebras is set to release Q2 financial results Wednesday afternoon, with analysts projecting core revenue of $191 million—an 84% increase year-over-yearThe consensus estimate calls for an adjusted loss of $0.17 per share, with profitability not anticipated until 2026Shares of CBRS have declined over 25% since the start of the year, fluctuating within a $162 to $244 range following its May debutDerivatives pricing indicates potential for an 11% surge by week’s end, with the put-to-call ratio standing at 0.56x for Aug. 14 expirationAnalyst community maintains a “Strong Buy” consensus with an average price objective of $282, suggesting more than 20% potential upsideCerebras Systems is scheduled to unveil its second-quarter financial performance on Wednesday afternoon, potentially setting the stage for another day of sharp price swings in CBRS stock on Thursday.Cerebras Systems Inc., CBRSThe company’s shares debuted on public markets in May with an initial offering price of $185. Trading commenced at $350 and briefly touched $386 before experiencing a substantial pullback that brought the stock down to $161 by late June. The subsequent period has seen the stock oscillate between $162 and $244.Throughout its 61 trading sessions, CBRS has registered movements exceeding 3% in either direction on 42 occasions—an exceptionally high level of price volatility.As the earnings announcement approaches, shares have retreated more than 25% from their year-to-date highs.Wall Street’s consensus projects core revenue reaching $191 million. This figure represents marginal sequential growth from the previous quarter while marking an 84% surge compared to the corresponding period last year.Cerebras employs a customized revenue reporting methodology. The company excludes pass-through revenue that generates zero margins while incorporating warrant amortization expenses. During the first quarter, this calculation adjusted reported sales of $193.4 million to a core revenue figure of $191.3 million.Regarding profitability, the Street anticipates an adjusted operating loss of $62 million alongside an adjusted loss per share of $0.17. An alternative consensus estimate places the expected loss at $0.21 per share, representing a modest improvement from Q1’s $0.22 loss.The company isn’t projected to achieve profitability until 2026.Derivatives Activity Signals Bullish SentimentOptions market positioning reveals a bullish tilt heading into the quarterly report. The put-to-call ratio for CBRS options contracts expiring Aug. 14 registers at 0.56x, indicating stronger demand for calls relative to puts.Strike prices on the upper end of these contracts hover just above $255. This suggests traders are positioning for approximately an 11% upward move through the end of the week if optimistic scenarios materialize.Recent technical indicators also show CBRS has climbed above its primary moving averages, while the RSI reading in the mid-50s indicates accumulating buying momentum.Nevertheless, skepticism remains warranted. The stock commands a price-to-sales valuation exceeding 80x despite operating at a loss. Additionally, company insiders have registered zero purchase transactions over the past year.Understanding Cerebras’ Business ModelCerebras manufactures the Wafer-Scale Engine (WSE), a processor spanning an entire 300mm silicon wafer. By integrating computing components and memory onto a single silicon substrate, the design eliminates a critical performance constraint in AI server infrastructure.This technological approach proves particularly effective for inference operations, which are experiencing rapid expansion as AI-powered applications proliferate.The company maintains a $25 billion order backlog, predominantly stemming from a multi-year agreement with OpenAI to lease Cerebras computing infrastructure via cloud services. OpenAI retains the right to expand this partnership.More recent partnerships include collaborations with Amazon and AMD, where WSE processors complement their existing hardware for accelerated inference processing. The Amazon agreement included equity warrants as part of the compensation structure.The analyst community’s overall stance on CBRS remains decidedly positive at “Strong Buy.” The $282 average price target indicates potential appreciation exceeding 20% from present trading levels.The post Cerebras (CBRS) Q2 Earnings Preview: Analyst Forecasts and Market Expectations appeared first on Blockonomi.